Delos Capital
A lower-middle market private equity investment firm based in New York City
Business Model:
Revenue: $10M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Delos Capital Information
Geographic Data
Address: 120 Fifth Avenue
City: New York
State: NY
Zip: 10011
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$24M
Social
Linkedin
Crunchbase
Metrics
5,263,878Website Global Rank
1,741Website Monthly Traffic
Twitter Followers
Description
Delos Capital is a lower-middle market private equity investment firm based in New York City. The Fund was formed in 2013 to invest in complex processes through Control Buyouts, Strategic Partnerships and Distressed Buyouts in companies with EBITDA of $10 – $30 million.
Contact Phone:
+12122574450
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2018 | US Fitness Products | Private Equity Round | - |
| 12/2022 | Rejoni | Series B | 0 |
| 7/2021 | Imperative Care | Series D | 0 |
| 5/2021 | Phanes Therapeutics | Series B | 0 |
| 12/2019 | Imperative Care | Series C | 0 |
| 6/2023 | Eccogene | Series B | 0 |
| 6/2016 | Allecra Therapeutics | Series B | 24.8M |
| 5/2017 | Intrinsic Therapeutics | Debt Financing | 28M |
| 5/2021 | LifeQ | Series A | 0 |
| 11/2019 | Clover Biopharmaceuticals | Series B | 43.2M |
| 11/2015 | BAROnova | Series D | 36.5M |
| 2/2021 | Clover Biopharmaceuticals | Series C | 230M |
| 6/2019 | Viron | Series A | 25M |
| 8/2015 | Syndax Pharmaceuticals | Series C | 0 |
| 12/2021 | OncoMyx Therapeutics | Series B | 0 |
| 4/2019 | Intrinsic Therapeutics | Series E | 52M |
| 11/2022 | Rgenta Therapeutics | Series A | 0 |
| 12/2021 | Viron | Series B | 50M |
| 9/2020 | Rejoni | Series A | 15M |
| 12/2021 | OncoMyx Therapeutics | Series B | 0 |
| 12/2021 | Viron Inc. | Series B | 0 |
| 7/2021 | Imperative Care | Series D | 0 |
| 5/2021 | LifeQ | Series A | 0 |
| 5/2021 | Phanes Therapeutics | Series B | 0 |
| 2/2021 | Clover Biopharmaceuticals | Series C | 0 |
| 9/2020 | Rejoni | Series A | 0 |
| 12/2019 | Imperative Care | Series C | 0 |
| 11/2019 | Clover Biopharmaceuticals | Series B | 0 |
| 6/2019 | Viron Inc. | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
